# Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis

> **NCT00831922** · PHASE2 · COMPLETED · sponsor: **AB Science** · enrollment: 43 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** masitinib (AB1010)
- **DRUG:** masitinib (AB1010)

## Key facts

- **NCT ID:** NCT00831922
- **Lead sponsor:** AB Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2006-10
- **Final completion:** —
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2018-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00831922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00831922, "Efficacy of Oral AB1010 in Adult Patients With Active Rheumatoid Arthritis". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00831922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*